Article
Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.
Diabetologia - 1 Jun 2011
van Hoek M, van Herpt T W, Dehghan A, Hofman A, Lieverse A G, van Duijn C M, Witteman J C M, Sijbrands E J G
Abstract excerpt
AIMS/HYPOTHESIS: An APOC3 promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether APOC3 polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants. METHODS: In the Rotterdam Study, a population-based prospective cohort (n = 7,983), Cox and logistic regression models were used to analyse the associations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
